TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
APYX

Apyx Medical Inc

Healthcare · Medical Devices

3.10$ +1.0% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Apyx Medical Inc (APYX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.4% of the shares are freely tradable; institutional investors hold 49.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 49.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 14.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 42Mio.

Largest Shareholders

Institutions

Institutions APYX
Name Stake (%) Shares Change (%) Date
Nantahala Capital Management, LLC 8.17 3,440,304 -13.4 03/31/2026
Archon Capital Management LLC 6.28 2,644,717 -5.2 06/30/2026
Royce & Associates, LP 6.20 2,611,224 +6.9 03/31/2026
Vanguard Capital Management, LLC 3.69 1,555,272 +0.0 03/31/2026
Essex Investment Management Company, LLC 2.70 1,136,630 +26.1 06/30/2026
AIGH Capital Management, LLC 2.68 1,128,343 +2.1 06/30/2026
Silverberg Bernstein Capital Management LLC 2.47 1,039,641 -0.1 06/30/2026

Funds

Funds APYX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.60 1,095,524 +0.0 07/31/2026
Royce Micro-Cap Trust 2.31 973,269 +46.7 06/30/2026
FTGF RY US SmCp Opp A USD Dis(A) 1.79 754,505 +10.7 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?